W. Rathmell
Last active: 4/27/2021

Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma.

Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, Cancer Genome Atlas Research Network
Cell. 2017 169 (7): 1327-1341.e23

PMID: 28622513 · PMCID: PMC5680778 · DOI:10.1016/j.cell.2017.05.046

Liver cancer has the second highest worldwide cancer mortality rate and has limited therapeutic options. We analyzed 363 hepatocellular carcinoma (HCC) cases by whole-exome sequencing and DNA copy number analyses, and we analyzed 196 HCC cases by DNA methylation, RNA, miRNA, and proteomic expression also. DNA sequencing and mutation analysis identified significantly mutated genes, including LZTR1, EEF1A1, SF3B1, and SMARCA4. Significant alterations by mutation or downregulation by hypermethylation in genes likely to result in HCC metabolic reprogramming (ALB, APOB, and CPS1) were observed. Integrative molecular HCC subtyping incorporating unsupervised clustering of five data platforms identified three subtypes, one of which was associated with poorer prognosis in three HCC cohorts. Integrated analyses enabled development of a p53 target gene expression signature correlating with poor survival. Potential therapeutic targets for which inhibitors exist include WNT signaling, MDM4, MET, VEGFA, MCL1, IDH1, TERT, and immune checkpoint proteins CTLA-4, PD-1, and PD-L1.

Copyright © 2017 Elsevier Inc. All rights reserved.

MeSH Terms (9)

Carcinoma, Hepatocellular DNA Methylation Genomics Genomics Humans Isocitrate Dehydrogenase Liver Neoplasms MicroRNAs Mutation

Connections (1)

This publication is referenced by other Labnodes entities: